Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1998
10/08/1998WO1998003661A3 Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components
10/08/1998DE19714913A1 Patient-specific immune adsorber
10/08/1998CA2292448A1 Attenuated respiratory syncytial virus
10/08/1998CA2286893A1 76 kda, 32 kda, and 50 kda helicobacter polypeptides and corresponding polynucleotide molecules
10/08/1998CA2286306A1 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/08/1998CA2285923A1 Methods and compositions for treating inflammatory bowel disease
10/08/1998CA2285692A1 Enhancement of immune response using targeting molecules
10/08/1998CA2285625A1 Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
10/08/1998CA2285565A1 Modified adenoviral fiber and target adenoviruses
10/08/1998CA2285416A1 Polymer-modified viruses
10/08/1998CA2285324A1 Targeted therapy to a biomedical device
10/08/1998CA2285039A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract
10/08/1998CA2284736A1 Mycobacterium recombinant vaccines
10/08/1998CA2284471A1 Fibrocyte-based cellular therapy formulations
10/08/1998CA2283799A1 Novel human serine carboxypeptidase
10/08/1998CA2227932A1 Gene encoding invasion protein of campylobacter jejuni
10/07/1998EP0869184A2 Vaccin for immunisation against TBE viral infections and method or its preparation
10/07/1998EP0869181A1 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
10/07/1998EP0869180A1 A TNF homologue, TL5
10/07/1998EP0869133A1 Production of gonorrheal PIB proteins and vaccines
10/07/1998EP0868918A2 Vaccines
10/07/1998EP0868522A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/1998EP0868517A1 Component of a staphylococcus signal transduction system
10/07/1998EP0868516A1 Novel tcts response regulator of staphylococcus aureus
10/07/1998EP0868515A1 Component of a staphylococcus signal transduction system
10/07/1998EP0868512A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
10/07/1998EP0868435A1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
10/07/1998EP0868434A1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs
10/07/1998EP0868433A1 Identification of antigenes from post-infection nematodes for the purpose of developing new anthelmintics and vaccines
10/07/1998EP0868198A1 FC$g(e)-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
10/07/1998EP0868197A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage
10/07/1998EP0868196A1 Synthetic vaccine for protection against human immunodeficiency virus infection
10/07/1998EP0748214B1 Liposomes and use thereof especially to obtain immunomodulating compositions
10/07/1998EP0548123B1 Anti-inflammatory factor, method of isolation, and use
10/07/1998CN1195297A Clostridium difficile toxins as mucosal adjuvants
10/07/1998CN1195295A Method and use of connective tissue growth factor as revellent
10/07/1998CN1195294A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligang antibodies, as therapeutic agents for treatment of immunological disease
10/07/1998CN1040126C Process for preparing protein
10/06/1998US5817792 DNA sequences encoding HIV-1 envelope muteins containing hypervariable domain deletions
10/06/1998US5817790 Reshaped human antibody to human interleukin-6 receptor
10/06/1998US5817789 Bind to cell surface receptors; genetic engineering
10/06/1998US5817771 Cell-targeted lytic pore-forming agents
10/06/1998US5817762 Mammalian tub protein
10/06/1998US5817754 Tandem synthetic HIV-1 peptide
10/06/1998US5817753 Antigenic modification of polypeptides
10/06/1998US5817646 Conveying active material into target cell
10/06/1998US5817637 Genetic immunization
10/06/1998US5817632 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/06/1998US5817631 Therapeutic uses of melanin
10/06/1998US5817617 Selectin and pertussis toxin derived peptides and uses thereof
10/06/1998US5817513 Immunotherapy for cancer
10/06/1998US5817512 Encapsidated recombinant viral nucleic acid and methods of making and using same
10/06/1998US5817511 Nucleotide sequence coding for variable regions of the α chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
10/06/1998US5817491 Enveloped vector particle; vesicular stomatitis virus
10/06/1998US5817483 Process for the production of stochastically-generated peptides,polypeptides or proteins having a predetermined property
10/06/1998US5817480 DNA encoding a histamine H2 receptor
10/06/1998US5817459 Nucleotide sequences of actinomycetales, oligonucleotides of said sequences and their use for detecting the presence of actinomycetales
10/06/1998US5817318 Synthetic peptides for an HIV-1 vaccine
10/06/1998US5817317 Clostridium perfringens vaccines
10/06/1998US5817316 Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding
10/06/1998US5817315 Recombinant vaccine
10/06/1998US5817314 Quillaja saponin adjuvant and vaccine formulation containing same
10/06/1998US5817313 Monoclonal antibodies and conjugates thereof useful for the treatment of cancer
10/06/1998US5817312 Sprayable immunoglobulins
10/06/1998US5817311 Graft verses host disease, transplant rejection
10/06/1998US5817308 Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance
10/06/1998CA2086631C Oral administration of immunologically active biomolecules and other therapeutic proteins
10/06/1998CA2072797C Use of tri (n-butyl) phosphate at low ph in solutions of biologically active proteins for enhanced virucidal activity
10/06/1998CA1340071C Dectection of infectious and inflammatory lesions using anti-leukocyte conjugates
10/06/1998CA1340068C Tumor diagnostic method
10/04/1998CA2234201A1 Rabies recombinant adenovirus
10/02/1998CA2232743A1 A tnf homologue, tl5
10/02/1998CA2226910A1 Sialoadhesin family member-2 (saf-2)
10/02/1998CA2223021A1 Novel human neurotensin receptor type 2 and splice variants thereof
10/01/1998WO1998043182A1 Coincidence detection method, products and apparatus
10/01/1998WO1998042868A2 Screening method for proline-rich proteins
10/01/1998WO1998042855A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors
10/01/1998WO1998042849A1 Keratinocyte derived kallikrein
10/01/1998WO1998042847A2 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination
10/01/1998WO1998042846A1 Methods to detect granulocytic ehrlichiosis
10/01/1998WO1998042842A1 A porin gene from campylobacter jejuni, related products and uses thereof
10/01/1998WO1998042841A1 Interferon related protein hkafe42
10/01/1998WO1998042752A1 Immunotherapeutic ctla-4 binding peptides
10/01/1998WO1998042751A1 Oxidised fragments of apolipoprotein b and their use
10/01/1998WO1998042750A1 ANTIGENIC FUSIONPROTEIN CARRYING GALα1,3GAL EPITOPES
10/01/1998WO1998042740A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection
10/01/1998WO1998042725A1 Methods and compositions for diagnosis and treatment of breast cancer
10/01/1998WO1998042721A1 Uronium salt conjugate vaccines
10/01/1998WO1998042718A1 Method for generating saccharide fragments
10/01/1998WO1998042384A1 Methods for delivering bioactive agents
10/01/1998WO1998042378A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
10/01/1998WO1998042377A1 Preventives or remedies for sensitized t cell-related diseases containing il-6 antagonists as the active ingredient
10/01/1998WO1998042376A1 Composition comprising immunoglobulin
10/01/1998WO1998042375A1 Detoxified mutants of bacterial adp-ribosylating toxins as parenteral adjuvants
10/01/1998WO1998042374A1 Chitosan induced immunopotentiation
10/01/1998WO1998042373A1 A method of preservation of vaccines with polybiguanide
10/01/1998WO1998042372A1 CARBOHYDRATE ANTIGENS WHICH IMMUNOREACT WITH POLYCLONAL ANTISERA AGAINST $i(H. PYLORI)
10/01/1998WO1998042357A1 Use of an extract of alchemilli vulgaris
10/01/1998WO1998042195A1 Replication-competent herpes simplex viruses
10/01/1998WO1998022580A3 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
1 ... 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 ... 1823